PDRN CareTelomere Shortening
Dr. Sarah Chen
PhD, Molecular Biology
Telomere shortening is the gradual loss of repetitive DNA sequences (TTAGGG repeats in humans) at the ends of chromosomes that occurs with each cell division [1].
Definition
Telomere shortening is the gradual loss of repetitive DNA sequences (TTAGGG repeats in humans) at the ends of chromosomes that occurs with each cell division [1]. Telomeres function as protective caps that prevent chromosome degradation, end-to-end fusion, and recognition as damaged DNA by the cell's repair machinery [1]. When telomeres erode below a critical length, cells enter a state of irreversible growth arrest known as replicative senescence β they remain alive but can no longer divide or perform their normal functions efficiently [1][4]. In the skin, telomere shortening is a fundamental driver of both intrinsic aging and the limited regenerative capacity observed in aged tissue [2].
How Telomere Shortening Drives Skin Aging
The End-Replication Problem
DNA polymerase cannot fully replicate the very ends of linear chromosomes, resulting in the loss of 50 to 200 base pairs of telomeric DNA per cell division [1]. In highly proliferative skin compartments β the basal layer of the epidermis and the dermal fibroblast population β this progressive shortening accumulates over decades of ongoing tissue renewal [2]. Neonatal skin fibroblasts typically carry telomeres of 10 to 15 kilobases, while fibroblasts from aged donors may have telomeres shortened to 5 to 7 kilobases [2].
Oxidative Acceleration
Telomeric DNA is particularly susceptible to oxidative damage because its guanine-rich repeats are preferential targets for reactive oxygen species (ROS) [4]. Oxidative lesions within telomeres are repaired less efficiently than those in the rest of the genome, meaning that oxidative stress accelerates telomere erosion beyond what replication alone would cause [4]. UV-exposed skin, which experiences chronic oxidative stress, shows more rapid telomere attrition than sun-protected areas on the same individual [2].
Senescence and Dermal Decline
When fibroblasts reach critical telomere shortness, they activate the p53/p21 checkpoint pathway and enter senescence [1][4]. Senescent fibroblasts cease producing collagen and elastin while secreting elevated levels of matrix metalloproteinases (MMPs) and pro-inflammatory cytokines β a phenomenon known as the senescence-associated secretory phenotype (SASP) [4]. The accumulation of these dysfunctional cells progressively degrades the dermal extracellular matrix, contributing to wrinkle formation, loss of elasticity, and thinning of the dermis [2].
PDRN and Telomere Biology
PDRN does not directly activate telomerase or lengthen telomeres, but it supports cellular health through mechanisms that are relevant to telomere maintenance [3][5]:
Nucleotide Salvage Pathway Support
PDRN provides a pool of purine and pyrimidine nucleotides through the salvage pathway [3][5]. These nucleotides are essential substrates for DNA repair enzymes, including those responsible for repairing oxidative lesions within telomeric sequences. By ensuring adequate nucleotide availability, PDRN supports the base excision repair (BER) pathway that addresses oxidative telomere damage [3].
Reducing Oxidative Telomere Damage
Through adenosine A2A receptor activation, PDRN suppresses the NF-kB-driven inflammatory cascade that amplifies ROS production [3]. By interrupting the inflammation-oxidative stress feedback loop, PDRN indirectly reduces the oxidative burden on telomeric DNA, potentially slowing the rate of non-replicative telomere erosion [3][5].
Sustaining Fibroblast Proliferative Capacity
PDRN stimulates fibroblast proliferation and metabolic activity [3][5]. By maintaining fibroblasts in a healthier, more functional state β with better DNA repair capacity and lower inflammatory burden β PDRN may help preserve their remaining proliferative potential rather than pushing them prematurely toward senescence.
Clinical Relevance
The connection between telomere biology and PDRN is particularly relevant for aging skin [2][3]:
- Photoaged skin β UV-accelerated telomere shortening makes sun-damaged areas prime candidates for PDRN therapy, which addresses both the oxidative cause and the regenerative deficit
- Mature skin rejuvenation β PDRN's ability to stimulate existing fibroblasts is especially valuable when the fibroblast population has been depleted by telomere-driven senescence
- Post-procedure recovery β Supporting DNA repair during healing helps protect the telomeric reserves of actively dividing cells at the wound site
References
- [1]Blackburn EH, Epel ES, Lin J. Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection. Science. 2015;350(6265):1193-1198. doi:10.1126/science.aab3389
- [2]Buckingham EM, Klingelhutz AJ. The role of telomeres in the ageing of human skin. Exp Dermatol. 2011;20(4):297-302. doi:10.1111/j.1600-0625.2010.01242.x
- [3]Squadrito F, Bitto A, Irrera N, et al.. Pharmacological Activity and Clinical Use of PDRN. Curr Pharm Des. 2017;23(27):3948-3957. doi:10.2174/1381612823666170516153716
- [4]Hewitt G, Jurk D, Marques FDM, et al.. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat Commun. 2012;3:708. doi:10.1038/ncomms1708
- [5]Colangelo MT, Galli C, Gentile P. Polydeoxyribonucleotide: A Promising Biological Platform for Dermal Regeneration. Curr Pharm Des. 2020;26(17):2049-2056.